 expand clinic evalu lovastatin excel studi result IV addit toler lovastatin random double-blind multicent diet-and-placebo-control studi dose-respons relationship lovastatin therapi lipid-modifi efficaci drug-rel advers event exclus criteria studi patient repres major patient moder hypercholesterolemia medic practic week american heart associ step diet total patient week treatment diet placebo lovastatin dosag mg day mg day advers event particular attent evalu liver muscl liver transaminas elev possibl hepatotox success elev aspart transaminas alanin aminotransferas time upper limit normal equal number placebo mg/day patient frequenc lovastatin mg/day mg/day patient group patient symptomat hepat dysfunct creatinin kinas CK elev upper limit normal placebo- lovastatin-tr patient muscl symptom similar frequenc group combin muscl symptom mark CK elev time upper limit normal patient mg/day group mg/day dose group patient rhabdomyolysi incid clinic laboratori advers event discontinu placebo group mg/day mg/day lovastatin treatment group new type advers experi treatment lovastatin adjunct reduct elev ldl cholesterol